lobbying_activities: 1655421

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1655421	19f18b81-ce4d-4718-9f55-7bc890bcccc7	1T	CUBIST PHARMACEUTICALS, INC.	40026226	CUBIST PHARMACEUTICALS	2015	first_quarter	HCR	Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM)Act; Ongoing discussions surrounding next steps for protecting and promoting incentives for the development of resistant pathogens including breakpoints, andtibiotic resistance, reimbursement issues for antibiotics, President's Council of Advisors on Science and Technology (PCSAT)	Health & Human Services, Dept of (HHS)			0	1	2015-02-02T17:43:37.717000-05:00